HEADLINE STOCKS-U.S. small/midcap stocks on the move on June 14

(For large-cap stocks on the move, click on [WATCH/US]) (Adds
Mohawk, Rosetta Stone and others)

June 14 (BestGrowthStock) – Some small and midcap stocks on the
move Monday:

TRICO MARINE SERVICES INC (TRMA.O: ), $0.50, down 32 pct

The debt-ridden oilfield services provider may seek
bankruptcy protection if it fails to make convertible notes
payment by June 17, despite amending its credit agreements,
according to a regulatory filing. [ID:nSGE65D0F4]

CERAGON NETWORKS, (CRNT.O: ), $8.39, up 16 pct

Shares of the company were up after brokerage Merriman
Curhan Ford raised its rating on Ceragon Networks to “buy.”.

CELL THERAPEUTICS INC (CTIC.O: ), $0.50, up 13 pct

The company said the Italian Medicines Agency approved
Italy-based NerPharMa DS to manufacture Cell Therapeutics’
experimental lymphoma drug pixantrone. Cell Therapeutics is
currently preparing to apply for European regulatory approval
for the drug.

L&L Energy Inc (LLEN.O: ), $10.10, up 9 pct

The coal company said it intends to buy at least a 51
percent stake in China’s Shunda Mining Co.

AVI BIOPHARMA (AVII.O: ), $1.57, up 8 pct

Shares of the company rose a day after Barron’s wrote that
the stock could rise significantly over the next year if it
continues to report favorable results from trials of its drugs.

THQ INC (THQI.O: ), $5.21, down 6.5 pct

The video game maker chopped its outlook for the first
quarter and full year 2011 on disappointing sales of one of its
products and the strengthening U.S. dollar. [ID:nSGE65D0ER]

MOHAWK INDUSTRIES (MHK.N: ), $52.93, up 5.7 pct

Shares of the company were up after brokerage Stifel
upgraded the building materials maker to “buy.”

LINCOLN NATIONAL CORP (LNC.N: ), $27.66, up 5 pct

The company said it would buy back $950 million of
preferred stock issued to the U.S. Treasury under the bailout
program by issuing stock and debt securities. [ID:nSGE65D0H5]

ONYX PHARMACEUTICALS (ONXX.O: ), $23.74, down 4 pct

Bayer (BAYGn.DE: ) and Onyx Pharmaceuticals failed to show in
a late-stage study that their Nexavar cancer drug prolongs the
lives of lung-tumour patients, the largest target group in the
cancer market.

ACTEL CORP (ACTL.O: ), $13.61, down 3.5 pct

The company said its second-quarter revenues are expected
to come in at the low end of its previous outlook.

ROSETTA STONE INC (RST.N: ), $23.66, up 3 pct

The language training software maker said it settled cases
against ten individuals involving copyright and trademark

JONES SODA CO (JSDA.O: ), $1.18, up 2.3 pct

The company said it entered into a committed equity
financing deal with Glengrove Small Cap Value Ltd that will
give the struggling US soft drinks maker the option to raise up
to $10 million over the next two years, in exchange for stock.

HUMAN GENOME SCIENCES INC (HGSI.O: ), $26.87, up 1.4 pct

The company said preliminary feedback from the U.S. health
regulator suggests it is unlikely for the company’s hepatitis C
drug to get approval at the dosing regimen applied for.

Stock Market Investing

(Reporting by Archana Shankar in Bangalore)

HEADLINE STOCKS-U.S. small/midcap stocks on the move on June 14